BODIPY vs Oil Red O for Lipid Droplets

Two chemistries, one shared limitation: neither resolves species.

The Comparison

PropertyBODIPY 493/503Oil Red O
ChemistryNeutral lipid-binding fluorophoreLysochrome dye, solubility-based
Live cellsYesNo
Fixed cellsYes, with compatible fixativeYes; requires fixation
QuantificationFluorescence intensity or object-basedColorimetric absorbance or image density
MultiplexingWith antibodies, if spectrally separatedPoor; strong red absorbance
Droplet morphologyExcellentGood
Solvent compatibilityAvoids non-polar mountants that dissolve dropletsSome mountants extract the dye
Dynamic rangeWide, with photobleachingNarrower; saturation at high lipid

Important distinction. BODIPY 493/503 binds neutral lipids generally — triglycerides and cholesteryl esters — with a preference that varies by species and by the local environment. Oil Red O is more strongly associated with triglycerides but also stains cholesteryl esters and some other lipids. Neither distinguishes triglyceride from cholesteryl ester, and neither reports phospholipid.

Part 1 — Practical Conditions

BODIPY.

  • • Working concentration 0.1–1 µg/mL, from a DMSO stock; higher concentrations produce non-specific membrane staining.
  • • Live imaging: 10–15 minutes at 37 °C, then wash; minimal illumination to limit photobleaching.
  • • Fixed: 4% PFA 10–15 minutes; avoid methanol, which extracts neutral lipid.
  • • Spectral: 493/503 excitation and emission for the standard probe; a 558/568 variant exists for multiplexing with green fluorophores.
  • • Quantification: per-droplet objects rather than total intensity, where the question concerns number or size.

Oil Red O.

  • • Stock in isopropanol, diluted into water or buffer immediately before use; precipitation is the main artefact.
  • • Fix with 4% PFA or formalin; wash thoroughly before staining.
  • • Staining 10–20 minutes, then wash and image in aqueous mountant.
  • • Quantification: extract the dye in isopropanol and read absorbance, or quantify image density — extraction is more reproducible for well-based assays.

Part 2 — Artefacts

ArtefactBODIPYOil Red O
Dye precipitationRare at working concentrationsCommon; crystals mimic droplets
Non-specific membrane stainingAt high concentrationLess so
PhotobleachingSignificant; affects quantitationNot applicable
Dye extraction by mountantWith non-polar mountantsWith some aqueous mountants
Fixative dissolving dropletsMethanol, some detergentsSame
SaturationHigh lipid loadsHigh lipid loads
Background from medium lipidsIf not washedIf not washed

Caveat on precipitated ORO. The crystals are intensely coloured and irregular, and they appear in the same size range as small droplets. Filtration of the working solution and a no-lipid control well are the standard checks; without them, a treated well with more precipitate looks like a well with more droplets.

Part 3 — Quantification That Supports a Claim

QuestionAppropriate measurementNot appropriate
Is there more neutral lipid?Total fluorescence per cell, normalisedNumber of visible droplets in a field
Are there more droplets?Object count per cell with a stated size thresholdTotal intensity
Are droplets larger?Per-object area distributionMean intensity
Is a treatment toxic?Viability in the same wellsDroplet abundance
Is the coat protein changed?PLIN2 immunofluorescence with droplet costainingPLIN2 alone

Readout note. Reporting "BODIPY intensity increased" answers the first question and is frequently described as if it answered the second or third. Since droplet number and size have different biology, a per-object analysis — even a simple histogram — is worth the extra analysis step.

Part 4 — When Neither Is Appropriate

  • • Species identification. Neither stain resolves triglyceride versus cholesteryl ester; lipidomics is required.
  • • Compartment assignment. Neither reports which membrane a lipid has entered.
  • • Flux. Neither reports synthesis or turnover; a pulse-chase with labelled fatty acid is required.
  • • Toxicity. Staining abundance is not injury; viability must be measured.
  • • Cholesterol-specific questions. Filipin is the appropriate free-cholesterol stain; the neutral lipid dyes report the esterified pool poorly and non-specifically.

Part 5 — Common Failures

  • • Precipitated ORO interpreted as droplets.
  • • BODIPY intensity reported as droplet number.
  • • Methanol fixation used with either stain.
  • • Non-polar mountant used with BODIPY, extracting the lipid along with the dye.
  • • Droplet counts without a stated size threshold.
  • • No viability measurement, so accumulation is read as injury.
  • • Staining after long serum exposure without washing, giving high background.
  • • Imaging settings changed between conditions, invalidating intensity comparison.

Part 6 — Where This Article Connects

This is the first analytical article of the lipid cluster, and it exists because most lipotoxicity figures begin with a droplet stain. The droplet biology article covers what the stain is showing biologically; the triglyceride assay article covers the quantitative alternative; and the lipidomics-based articles cover species resolution, which no stain provides.

If you need droplet imaging with per-object quantification and viability in the same wells, we can scope the protocol with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Stain performance, linear range and background vary with cell type, fixative, mountant and imaging settings; the conditions here are starting points requiring local validation.

Neutral lipid staining does not identify lipid species, and it does not establish toxicity.

Scientific interpretation and experimental design

  • • Two chemistries, one limitation. Neither resolves species.
  • • ORO precipitates. Filter it and use a no-lipid control.
  • • BODIPY bleaches. Fixed-time acquisition across conditions.
  • • Avoid methanol. It extracts the object.
  • • Object-based analysis for number and size.
  • • Staining is not injury. Measure viability.

Selected references for further reading

  • • Listenberger LL, Brown DA. Fluorescent detection of lipid droplets and associated proteins. Current Protocols in Cell Biology. 2007;Chapter 24:Unit 24.2.
  • • Mehlem A, et al. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nature Protocols. 2013;8:1149–1154.
  • • Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nature Reviews Molecular Cell Biology. 2019;20:137–155.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: